MarketPeel
Insider Trading Intelligence
KM

Kate Mckinley

RANI
CHIEF BUSINESS OFFICER · RANI THERAPEUTICS HOLDINGS, INC. · CIK 0001979211
FILING MIX · LIFETIME88%/12%
BUYS
7
SELLS
1
TOTAL VALUE
$30.0K
COMPANIES
1
ACTIVE SINCE
May 2023
HOLDINGS NOW
805,500
AVG SELL PX
TRADE KIND
SHOWING 8 / 8
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons · 1 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Kate Mckinley, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+0.00%-15.66%-1.83%-13.83%-13.83%
14d1+0.00%-14.46%-1.19%-13.27%-13.27%
30d1+0.00%-21.69%-3.45%-18.23%-18.23%
60d1+0.00%-15.06%+0.52%-15.58%-15.58%
90d1+0.00%-12.05%-8.43%-3.62%-3.62%
180d1+0.00%-65.48%+0.16%-65.64%-65.64%
1y1+0.00%-19.28%+13.55%-32.83%-32.83%
2y1(1 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
RANI · 805,500 shares · as of Jun 3, 2026
0201,375402,750604,125805,500202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 7 buys / 1 sellsCOVERAGE · 13 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
RANI
RANI THERAPEUTICS HOLDINGS, INC.
PURCHASEGRANT
Stock grant
805,500805,500Jun 3, 2026Jun 5, 2026View →
RANI
RANI THERAPEUTICS HOLDINGS, INC.
PURCHASEGRANT
Stock grant
120,000120,000Aug 1, 2025Aug 5, 2025View →
RANI
RANI THERAPEUTICS HOLDINGS, INC.
PURCHASEGRANT
Stock grant
325,000325,000May 23, 2025May 23, 2025View →
RANI
RANI THERAPEUTICS HOLDINGS, INC.
PURCHASE
Chief Business Officer
17,960$1.67$30.0K17,960Dec 13, 2024Dec 16, 2024View →
RANI
RANI THERAPEUTICS HOLDINGS, INC.
PURCHASEGRANT
Stock grant
323,500323,500Mar 21, 2024Mar 22, 2024View →
RANI
RANI THERAPEUTICS HOLDINGS, INC.
PURCHASEGRANT
Stock grant
250,000250,000Dec 16, 2023Dec 19, 2023View →
RANI
RANI THERAPEUTICS HOLDINGS, INC.
SALE
Chief Business Officer
250,0000Dec 16, 2023Dec 19, 2023View →
RANI
RANI THERAPEUTICS HOLDINGS, INC.
PURCHASEGRANT
Stock grant
250,000250,000May 22, 2023Aug 8, 2023View →
Other insiders · RANI
Loading peer insiders…
About this filer
CIK 0001979211
ROLE
Chief Business Officer
PRIMARY
RANI
COMPANIES
1
ACTIVE SINCE
May 2023
MARKETPEEL · /INSIDER/0001979211DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback